Loading...

ENZO BIOCHEM INC Disposals and divestitures 8-K Filing

NZ B

ENZO BIOCHEM INC

()

2023 8-K

Merger Announcement

Merger Approved

Merger of Equals

Strategic Evaluation

Stock Delisting

Voluntary Delisting

Financial Results

Annual Meeting Results

Class Action Settlement

NYSE Non-Compliance

Board Appointment

Financial Results

Settlement Agreement

Regulatory Agreement

Departure of Directors or C...

Management Changes

Financial Results Announcement

Salary Increases and Equity...

Appointment of CEO and CFO

Appointment of Chairman and...

Departure of CEO and Appoin...

Other Special Situation

Quantitative Data

Financial Update

Special Meeting Approval

Securities Purchase Agreement

Supplemental Disclosures to...

Filing with Quantitative Data

Credit Facility Agreement

Asset Purchase Agreement

Annual Meeting of Shareholders

External Links:

Enzo Biochem, Inc. has completed the sale of certain assets and the assignment of certain liabilities of their clinical laboratory business for $113.25 million in cash to Laboratory Corporation of America Holdings.

AI Assistant

ENZO BIOCHEM INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.